SK Chemicals signs exclusive supply agreement of Parkinson’s treatment with Portuguese BIAL

Published: 2018-03-07 14:41:17

Updated: 2018-03-07 14:41:17

SK Chemicals will supply treatments for Parkinson’s disease patients with motor fluctuation in Korea.

SK Chemicals announced on the 5^th that the company has signed a license agreement of exclusive supply of ‘Ongentys(generic name: opicapone)’ in Korea with the largest Portuguese pharmaceutical company ‘BIAL.’

Ongentys is a drug which adjust dosage of levodopa, a treatment which supplement dop...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.